Redwood Park Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-274
Closed -$12.3K 325
2025
Q3
$12.3K Buy
274
+4
+1% +$187 0.01% 166
2025
Q2
$12.5K Sell
270
-41
-13% -$2.01K 0.01% 161
2025
Q1
$19K Hold
311
0.02% 140
2024
Q4
$17.6K Buy
+311
New +$17.4K 0.01% 147

Other funds holding BMY

Redwood Park Advisors's BMY Position: Q4 2025 in Review

Redwood Park Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 274 shares — an estimated $12.3K sold.

Redwood Park Advisors first reported a position in BMY in Q4 2024 and held it in 4 quarters. The position peaked at $19K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Redwood Park Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Redwood Park Advisors sold 274 Bristol-Myers Squibb shares in Q4 2025, an estimated $12.3K.
  • Redwood Park Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 4 quarters.
  • Redwood Park Advisors's Bristol-Myers Squibb position peaked at $19K in Q1 2025.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Redwood Park Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.